Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease
In December, 2021 at the IXth All-Russian Congress «Pulmonary Hypertension 2021» the first Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart disease in adults were approved. The expert group discussed many contentious issues, including the...
Saved in:
| Main Authors: | A. A. Shmalts, S. V. Gorbachevsky, T. V. Martynyuk, S. N. Nakonechnikov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2022-10-01
|
| Series: | Евразийский Кардиологический Журнал |
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/6339 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vasoreactive testing prevalence and characteristics in patients with idiopathic pulmonary arterial hypertension
by: Goncharova Natalia, et al.
Published: (2025-01-01) -
Calculation of hemodynamics by the Fick method in pulmonary hypertension associated with congenital heart defects
by: A. A. Shmalts, et al.
Published: (2022-05-01) -
Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)
by: I. E. Chazova, et al.
Published: (2022-05-01) -
CLINICAL FEATURES OF PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL SYSTEMIC-TO-PULMONARYSHUNTS
by: S. Ye. Gratsianskaya, et al.
Published: (2017-12-01) -
Case Report: Non-reactive vasoreactivity testing in a patient with patent ductus arteriosus with pulmonary hypertension: is there still a way to turn things around?
by: Sisca Natalia Siagian, et al.
Published: (2025-08-01)